Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 465274013 | Erythromycin 250mg e/c granules in capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 717835018 | Erythromycin 250mg e/c granules in capsule (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1190304013 | Erythromycin 250mg e/c granules in capsule (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erythromycin 250mg e/c granules in capsule | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Has active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Erythromycin 250mg e/c granules in capsule | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)